IN
NASDAQ · INCR
InterCure Ltd.
Healthcare · Drug Manufacturers - Specialty & Generic
$5.29
Up+$0.13 (+2.52%)
Updated Sep 15, 2026, 12:14 PM
SID Score
5.5/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 67.8M
- P/E ratio
- -3.23
- Dividend yield
- 0.00%
- 52-week range
- $0.72 – $6.10
- Volume
- 2.87K
- Avg. volume
- 58.85K
Price performance
INCR price history
1M range · 20 trading sessions · Daily adjusted prices
INCR closed at $5.29 after 20 trading sessions, up 458.13% for the selected period.
- Last close
- $5.29
- Period change
- +458.13%
- Period low
- $0.95
- Period high
- $5.95
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 14, 2026 | $5.12 | $5.32 | $5.12 | $5.29 | 2.87K |
| Sep 11, 2026 | $5.26 | $5.26 | $5.16 | $5.16 | 2.53K |
| Sep 10, 2026 | $5.23 | $5.27 | $5.23 | $5.24 | 5.22K |
| Sep 9, 2026 | $5.47 | $5.47 | $5.18 | $5.25 | 7.93K |
| Sep 8, 2026 | $5.46 | $5.60 | $5.34 | $5.39 | 9.25K |
| Sep 4, 2026 | $5.33 | $5.45 | $5.31 | $5.42 | 6.34K |
| Sep 3, 2026 | $5.27 | $5.42 | $5.22 | $5.26 | 34.91K |
| Sep 2, 2026 | $5.47 | $5.52 | $5.261 | $5.40 | 11.86K |
| Sep 1, 2026 | $5.79 | $5.79 | $5.475 | $5.51 | 10.81K |
| Aug 31, 2026 | $5.79 | $5.81 | $5.56 | $5.76 | 17.19K |
| Aug 28, 2026 | $5.69 | $5.89 | $5.69 | $5.78 | 5.33K |
| Aug 27, 2026 | $5.84 | $5.84 | $5.61 | $5.68 | 9.46K |
| Aug 26, 2026 | $5.94 | $6.10 | $5.68 | $5.95 | 61.32K |
| Aug 25, 2026 | $5.80 | $5.97 | $5.5301 | $5.88 | 98.02K |
| Aug 24, 2026 | $5.44 | $5.84 | $4.80 | $5.48 | 356.13K |
| Aug 21, 2026 | $4.40 | $4.40 | $4.2575 | $4.2575 | 584.86K |
| Aug 20, 2026 | $4.45 | $4.4505 | $4.301 | $4.345 | 2.69K |
| Aug 19, 2026 | $4.6285 | $4.754 | $4.2395 | $4.65 | 14.78K |
| Aug 18, 2026 | $4.888 | $4.888 | $4.635 | $4.75 | 298.05 |
| Aug 17, 2026 | $0.97 | $0.9759 | $0.9478 | $0.9478 | 12.64K |
Latest INCR news
The latest Smart Investors Daily articles mentioning INCR.
Stock researchResearch & News · SID Coverage
Loading stock research…
